Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00007267 · ClinicalTrials.gov registry record · Phase 2

Psychological Treatments for Scleroderma

A Phase 2 study of Depression and Pain, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 2
Development phase
89
Enrollment target
1
Study location

NCT00007267 is a Phase 2 study of Depression and Pain that has completed, run by Johns Hopkins University. The registered enrollment target is 89 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00007267, a Phase 2 study of Depression and Pain, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 2
Development phase
89 participants
Enrollment target
1
Study location

Study Summary

This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. The study will also evaluate the impact of depression on the two psychological treatments. Because psychological approaches requiring a trained professional can be expensive and are often not available to most patients, this study will also look at the effectiveness of a self-help treatment approach.

Conditions Studied

Depression Pain Systemic Sclerosis Scleroderma

Interventions

  • BEHAVIORAL Cognitive behavioral therapy
  • BEHAVIORAL Disease/health education
  • BEHAVIORAL Self-help cognitive behavioral intervention facilitated by a psychologist

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2001-06
Est. Completion 2006-06
Phase Phase 2

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00007267

The ClinicalTrials.gov registry entry for NCT00007267 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Cognitive behavioral therapy is the first listed.

NCT00007267 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00007267 about?

NCT00007267 is a clinical study titled "Psychological Treatments for Scleroderma". This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. The study will also evaluate the impact of depression on the two ps...

What is the current status of trial NCT00007267?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2001-06. Estimated completion is 2006-06.

What conditions does trial NCT00007267 study?

This clinical trial studies the following conditions: Depression, Pain, Systemic Sclerosis, Scleroderma.

What interventions are being tested in trial NCT00007267?

The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL), Disease/health education (BEHAVIORAL), Self-help cognitive behavioral intervention facilitated by a psychologist (BEHAVIORAL).

Who is sponsoring clinical trial NCT00007267?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00007267 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Pain

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.